{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:53:58Z","timestamp":1794066838522,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eururo.2025.10.010","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:41:18Z","timestamp":1761946878000},"page":"487-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-918X","authenticated-orcid":false,"given":"Valeria","family":"Panebianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Galgano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndon","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdair F.","family":"Muglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Redd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Alberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.10.010_b0005","series-title":"Global Cancer Observatory: cancer today","author":"Ferlay","year":"2024"},{"key":"10.1016\/j.eururo.2025.10.010_b0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2025.10.010_b0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41585-023-00830-2","article-title":"Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System","volume":"21","author":"Panebianco","year":"2024","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/s1677-5538.ibju.2021.0560","article-title":"VI-RADS score system \u2013 a primer for urologists","volume":"48","author":"Nicola","year":"2022","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0035","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00345-022-03969-6","article-title":"The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations","volume":"40","author":"Del Giudice","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0045","series-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer","author":"Witjes","year":"2024"},{"key":"10.1016\/j.eururo.2025.10.010_b0050","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1007\/s00330-024-11327-w","article-title":"Diagnostic accuracy and inter-reader agreement of the nacVI-RADS for bladder cancer treated with neoadjuvant chemotherapy: a prospective validation study","volume":"35","author":"Dehghanpour","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bju.16191","article-title":"Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer","volume":"133","author":"Necchi","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.10.010_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.euo.2020.06.010","article-title":"Best practices to optimise quality and outcomes of transurethral resection of bladder tumours","volume":"4","author":"Mostafid","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0065","doi-asserted-by":"crossref","unstructured":"Bakaloudi DR, Koehne EL, Voutsinas JM, et al. Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: a retrospective cohort study. Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.024.","DOI":"10.1016\/j.urolonc.2025.07.024"},{"key":"10.1016\/j.eururo.2025.10.010_b0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11547-022-01513-5","article-title":"A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study","volume":"127","author":"Bicchetti","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.eururo.2025.10.010_b0075","doi-asserted-by":"crossref","DOI":"10.1177\/17562872211039583","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications","volume":"13","author":"S\u00e9guier","year":"2021","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1148\/radiol.2511080873","article-title":"Urinary Bladder Cancer: diffusion-weighted MR imaging\u2014accuracy for diagnosing T stage and estimating histologic grade","volume":"251","author":"Takeuchi","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2025.10.010_b0085","series-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer","author":"van der Heijden","year":"2025"},{"key":"10.1016\/j.eururo.2025.10.010_b0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data","volume":"48","author":"Vale","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0095","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.annonc.2020.09.011","article-title":"Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study","volume":"31","author":"Bandini","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0100","doi-asserted-by":"crossref","first-page":"802","DOI":"10.21037\/tau-23-124","article-title":"Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives","volume":"12","author":"Fan","year":"2023","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40644-023-00632-0","article-title":"Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI","volume":"23","author":"Woo","year":"2023","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2023.06.007","article-title":"Updated overall survival by circulating tumor DNA status from the phase 3 IMvigor010 trial: adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma","volume":"85","author":"Powles","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","article-title":"Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report","volume":"47","author":"Pecoraro","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jmri.27090","article-title":"MRI of bladder cancer: local and nodal staging","volume":"52","author":"Caglic","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0125","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1007\/s00330-022-08813-4","article-title":"Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field","volume":"32","author":"Watanabe","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12880-025-01595-3","article-title":"Comparative diagnostic performance of VI-RADS based on biparametric and multiparametric MRI in predicting muscle invasion in bladder cancer","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0135","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233459","article-title":"Multiparametric MRI for bladder cancer: a practical approach to the clinical application of VI-RADS","volume":"314","author":"Pecoraro","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2025.10.010_b0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00261-019-02190-1","article-title":"Validation of Vesical Imaging Reporting and Data System for assessing muscle invasion in bladder tumor","volume":"45","author":"Kim","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0145","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190401","article-title":"Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with Vesical Imaging Reporting and Data System (VI-RADS) application","volume":"92","author":"Makboul","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","article-title":"Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non\u2013muscle-invasive bladder cancer patients candidate for repeated transurethral resection","volume":"77","author":"Del Giudice","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0155","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bju.15188","volume":"126","author":"Del Giudice","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.10.010_b0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.21037\/tau.2020.02.16","article-title":"Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer","volume":"9","author":"Liu","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40644-020-00304-3","article-title":"Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0170","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/jmri.27676","article-title":"Detecting muscle invasion of bladder cancer using a proposed magnetic resonance imaging strategy","volume":"54","author":"Wang","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0175","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1007\/s00330-021-07765-5","article-title":"The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study","volume":"31","author":"Metwally","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0180","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14584","article-title":"The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer","volume":"75","author":"Erkoc","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2025.10.010_b0185","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1038\/s41598-022-19273-7","article-title":"Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS","volume":"12","author":"Noh","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2025.10.010_b0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.euo.2022.07.006","article-title":"Diagnostic value of the Vesical Imaging-Reporting and Data System in bladder urothelial carcinoma with variant histology","volume":"6","author":"Arita","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jmri.27807","article-title":"Preliminary exploration of the application of Vesical Imaging-Reporting and Data System (VI-RADS) in post-treatment patients with bladder cancer: a prospective single-center study","volume":"55","author":"Cao","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ajur.2021.06.001","article-title":"Validation of Vesical Imaging Reporting and Data System score for the diagnosis of muscle-invasive bladder cancer: a prospective cross-sectional study","volume":"9","author":"Ghanshyam","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","article-title":"Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?","volume":"47","author":"Aslan","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21037\/tau-22-704","article-title":"Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx","volume":"12","author":"Kim","year":"2023","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0215","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1016\/j.crad.2024.01.031","article-title":"Vesical Imaging-Reporting and Data System (VI-RADS) as a grouping imaging biomarker combined with a decision-tree mode to preoperatively predict the pathological grade of bladder cancer","volume":"79","author":"Cao","year":"2024","journal-title":"Clin Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jmri.29103","article-title":"Development and validation of an MRI-based nomogram for preoperative detection of muscle invasion in VI-RADS 3","volume":"60","author":"Yu","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0225","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.acra.2023.09.005","article-title":"Amide Proton transfer-weighted MRI and diffusion-weighted imaging in bladder cancer: a complementary tool to the VI-RADS","volume":"31","author":"Kong","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0230","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1007\/s00261-022-03669-0","article-title":"Inter-reader reliability of the Vesical Imaging-Reporting and Data System (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"47","author":"Jazayeri","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urolonc.2021.11.008","article-title":"Diagnostic accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) in suspected muscle invasive bladder cancer: a systematic review and diagnostic meta-analysis","volume":"40","author":"Jazayeri","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0240","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1007\/s00330-020-06802-z","article-title":"Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis","volume":"30","author":"Luo","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.10.010_b0245","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","article-title":"Diagnostic performance of Vesical Imaging Reporting and Data System for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"3","author":"Woo","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0250","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/20905998.2024.2442256","article-title":"Implementing VIRADS score for image-guided assessment of muscle invasiveness in bladder cancer pre-TURBT: an updated meta-analysis","volume":"23","author":"Al-Qudimat","year":"2025","journal-title":"Arab J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0255","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00345-024-05101-2","article-title":"The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer","volume":"42","author":"Kozikowski","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0260","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233020","article-title":"Neoadjuvant chemotherapy VI-RADS scores for assessing muscle-invasive bladder cancer response to neoadjuvant immunotherapy with multiparametric MRI","volume":"313","author":"Brembilla","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2025.10.010_b0265","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12880-024-01441-y","article-title":"Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer","volume":"24","author":"De Maeseneer","year":"2024","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12880-024-01547-3","article-title":"Diffusion-weighted MRI-derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancer","volume":"25","author":"Razzaghdoust","year":"2025","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.eururo.2025.10.010_b0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1245\/s10434-024-16424-0","article-title":"Prospective assessment of VI-RADS with muscle invasion in urinary bladder cancer and its implication on re-resection\/restaging TURBT patients","volume":"32","author":"Kural","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0280","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1200\/JCO-25-00779","article-title":"Randomized comparison of magnetic resonance imaging versus transurethral resection for staging new bladder cancers: results from the prospective BladderPath trial","volume":"43","author":"Bryan","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0285","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.euo.2025.03.005","article-title":"Challenges in defining clinical complete response to systemic therapy in muscle-invasive bladder cancer: insights from the EORTC STARBURST project","volume":"8","author":"Masson-Lecomte","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.10.010_b0290","doi-asserted-by":"crossref","unstructured":"Panebianco V, Dehghanpour A. The BladderPath trial and bladder MRI: what\u2019s next? Eur Radiol. In press. https:\/\/doi.org\/10.1007\/s00330-025-11685-z.","DOI":"10.1007\/s00330-025-11685-z"},{"key":"10.1016\/j.eururo.2025.10.010_b0295","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.euf.2019.03.012","article-title":"Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes","volume":"6","author":"Subiela","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.10.010_b0300","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.10.010_b0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JU.0000000000003981","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; Amended 2020, 2024)","volume":"212","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825047694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825047694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:34:50Z","timestamp":1779917690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825047694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0302283825047694"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.10.010","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}